Library Generation via Postcondensation Modifications of Isocyanide-Based Multicomponent Reactions

Methods in Enzymology

Volumn 369, Issue , 2003, Pages 469-496

  Hulme, Christopher ^b   Bienaymé, Hugues ^a   Nixey, Thomas ^b   Chenera, Balan ^b   Jones, Wyeth ^b   Tempest, Paul ^b   Smith, Adrian L ^b  

^a INST DE RECHERCHES SUR LA CATALYSE   (France)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; AMYLOID BETA PROTEIN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZIMIDAZOLE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HETEROCYCLIC COMPOUND; HYPNOTIC AGENT; IMIDAZOLINE DERIVATIVE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; QUINOXALINONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; CHEMICAL MODIFICATION; CHEMICAL REACTION; COMBINATORIAL LIBRARY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; METHODOLOGY; POLYMERIZATION; PRIORITY JOURNAL; PURIFICATION; REACTION ANALYSIS; STOICHIOMETRY;

EID: 0013076055     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(03)69024-5     Document Type: Article

References (96)

1. R. S. McDowell, B. K. Blackburn, T. R. Gadek, L. R. McGee, T. Rawson, M. E. Reynolds, K. D. Robarge, T. C. Somers, E. D. Thorsett, M. Tischler, R. R. Webb, and M. C. Venuti, J. Am. Chem. Soc. 116, 5077 (1994).
2. N. S. Cho, K. Y. Song, and C. Parkanyi, J. Heterocycl. Chem. 26, 1807 (1989).
3. L. H. Sternbach, J. Med. Chem. 22, 1 (1979).
4. R. Pauwels, K. Andries, J. Desmyler, D. Schols, M. J. Kukla, H. J. Breslin, A. Raeymaeckers, J. Van Gelder, R. Woostenborgles, J. Heykants, K. Schellekens, M. A. C. Jansen, E. D. Clercq, and P. A. J. Janssen, Nature 343, 470 (1990).
5. M. G. Bock, R. M. Dipardo, B. E. Evans, K. E. Rittle, W. L. Whitter, D. F. Veber, P. S. Anderson, and R. M. Freidinger, J. Med. Chem. 32, 13 (1989).
6. B. A. Bunin and J. A. Ellman, J. Am. Chem. Soc. 114, 10997 (1992).
7. (a) T. A. Keating and R. W. Armstrong, J. Am. Chem. Soc. 118, 2574 (1996).
8. For earlier syntheses of 1,4-benzodiazepines see (b) M. Gates, J. Org. Chem. 45, 1675 (1980).
9. (c) M. Uskokovic, J. Iacobelli, and W. Wenner, J. Org. Chem. 27, 3606 (1962).
10. (a) I. Ugi, Angew. Chem. Int. Ed. Engl. 1, 8 (1962).
11. (b) I. Ugi and C. Steinbruckner, Chem Ber. 94, 734 (1961).
12. (c) I. Ugi, A. Domling, and W. Horl, Endeavor 18, 115 (1994).
13. (a) T. A. Keating and R. W. Armstrong, J. Am. Chem. Soc. 117, 7842 (1995).
14. (b) F. K. Rosendahl and I. Ugi, Ann. Chem. 666, 65 (1963).
15. T. A. Keating and R. W. Armstrong, J. Org. Chem. 61, 8935 (1996).
16. C. Hulme, S.-Y. Tang, C. J. Burns, I. Morize, and R. Labaudiniere, J. Org. Chem. 63, 8021 (1998).
17. N-Boc anthranilic acids are readily accessible in multigram quantities via the synthetic route shown in the scheme below from the corresponding anthranilic acid or isatin. N-Boc diamines are readily available as described in A. P. Krapcho, M. J. Maresh, and J. Lunn, Synthetic Commun. 23, 2443 (1993). The majority of available N-Boc anthranilic acids may be purchased from Anaspec AA. Diagram presented.
18. C. Hulme, M. Morrissette, F. Volz, and C. Burns, Tetrahedron Lett. 39, 1113 (1998).
19. (a) C. Hulme, J. Peng, B. Louridas, P. Menard, P. Krolikowski, and N. V. Kumar, Tetrahedron Lett. 39, 8047 (1998).
20. (b) Note that MP-carbonate (Argonaut Technologies) was used to facilitate cyclization in the ketopiperazine series.
21. (c) I. Ugi and A. V. Zychlinski, Heterocycles 49, 29 (1998).
22. T. Nixey, P. Tempest, and C. Hulme, Tetrahedron Lett. 43, 1637 (2002).
23. C. Hulme, L. Ma, J. Romano, M. P. Cherrier, J. Salvino, and R. Labaudiniere, Tetrahedron Lett. 41, 1889 (2000).
24. (a) T. A. Keating and R. W. Armstrong, J. Am. Chem. Soc. 118, 2574 (1996).
25. (b) A. M. M. Mjalli, S. Sarshar, and T. J. Baiga, Tetrahedron Lett. 37, 2943 (1996).
26. PS-TsNHNH2 was purchased from Argonaut Technologies, Foster City, CA.
27. J. F. Miller, K. Koch, and A. D. Piscopio, 214th ACS National Meeting, Las Vegas, Nevada, ORGN-232 (1997).
28. T. Lindhorst, H. Bock, and I. Ugi, Tetrahedron 55, 7411 (1999).
29. A. L. Kennedy, A. M. Fryer, and J. A. Josey, Org. Lett. 4, 1167 (2002).
30. J. J. Chen, A. Golebiowski, J. McClenaghan, S. R. Klopfenstein, and L. West, Tetrahedron Lett. 42, 2269 (2001).
31. (a) C. Hulme, J. Peng, G. Morton, J. M. Salvino, T. Herpin, and R. Labaudiniere, Tetrahedron Lett. 39, 7227 (1998).
32. (b) D. L. Flynn, R. E. Zelle, and P. A. Grieco, J. Org. Chem. 48, 2424 (1983).
33. M. J. Plunkett and J. A. Ellman, J. Org. Chem. 60, 6006 (1995).
34. C. Hulme and M. P. Cherrier, Tetrahedron Lett. 40, 5295 (1999).
35. J. Kelder, P. D. J. Grootenhuis, D. M. Bayada, L. P. C. Delbressine, and J.-P. Ploemen, Pharm. Res. 16, 1514 (1999).
36. A. M. Davis and S. J. Teague, Angew. Chem. Int. Ed. Engl. 38, 736 (1999).
37. C. Hulme, L. Ma, and R. Labaudiniere, Tetrahedron Lett. 41, 1509 (2000).
38. A. K. Szardenings, T. S. Burkoth, H. H. Lu, D. W. Tien, and D. A. Campbell, Tetrahedron 53, 6573 (1997).
39. G. Frater, U. Muller, and W. Gunther, Tetrahedron Lett. 22, 4221 (1981).
40. M. S. Iyer, K. M. Gigstad, N. D. Namdev, and M. Lipton, J. Am. Chem. Soc. 118, 4910 (1996).
41. C. Hulme, L. Ma, J. Romano, G. Morton, S.-Y. Tang, M. P. Cherrier, S. Choi, and R. Labaudiniere, Tetrahedron Lett. 41, 1883 (2000).
42. I. Ugi and C. Steinbruckner, Chem. Ber. 94, 2802 (1961).
43. T. A. Keating and R. W. Armstrong, J. Org. Chem. 63, 867 (1998).
44. (a) K. Karabelas, M. Lepisto, and P. Sjo, World Patent WO9932483 (1999).
45. (b) K. E. Miller, J. F. Carpenter, and R. R. Brooks, Cardiovasc. Drugs Ther. 12, 83 (1998).
46. (c) A. E. Busch, B. Eigenberger, N. K. Jurkiewicz, J. J. Salata, A. Pica, H. Suessbrich, and F. B. Lang, Br. J. Pharmacol. 123, 23 (1998).
47. (d) J. J. Edmunds, S. Klutchko, J. M. Hamby, A. M. Bunker, C. J. C. Connolly, R. T. Winters, J. Quin, I. Sircar, and J. C. Hodges, J. Med. Chem. 38, 3759 (1995).
48. For previous syntheses of hydantoins see (e) S. Hanessian and R.-Y. Yang, Tetrahedron Lett. 37, 5835 (1996).
49. (f) K. M. Short, B. W. Ching, and A. M. M. Mjalli, Tetrahedron Lett. 37, 7489 (1996).
50. (g) B. A. Dressman, L. A. Spangle, and S. W. Kaldor, Tetrahedron Lett. 37, 937 (1996).
51. (h) S. W. Kim, S. Y. Ahn, J. S. Koh, J. H. Lee, S. Ro, and H. Y. Cho, Tetrahedron Lett. 38, 4603 (1997).
52. C. Hulme, M. Morrissette, and L. Ma, Tetrahedron Lett. 40, 7925 (1999).
53. PS-NCO was purchased from Argonaut Technologies, Foster City, California.
54. P. Tempest, M. Kelly, and C. Hulme, Tetrahedron Lett. 42, 4959 (2001).
55. (a) M. Pigini, P. Bousquet, A. Carotti, M. Dontenwill, M. Gianella, R. Morieoni, A. Piergentili, W. Quaglia, S. K. Tayebati, and L. Brasili, Bioorg. Med. Chem. 5, 833 (1997).
56. (b) M. Harfenist, D. J. Heuser, C. T. Joyner, J. F. Batchelor, and H. L. White, J. Med. Chem. 39, 1857 (1996).
57. (c) H. C. Jackson, I. J. Griffin, and D. J. Nutt, Br. J. Pharmacol. 104, 258 (1991).
58. (d) E. Tibirica, J. Feldman, C. Mermet, F. Gonon, and P. Bousquet, J. Pharmacol. 134, 1 (1987).
59. (a) I. Gilbert, D. C. Rees, and R. S. Richardson, Tetrahedron Lett. 32, 2277 (1991),
60. (b) R. C. F. Jones and G. J. Ward, Tetrahedron Lett, 29, 3853 (1988).
61. (a) Z. Zhao, D. Arnaiz, B. Griedel, S. Sakata, J. Dallas, M. Whitlow, L. Trinh, J. Post, A. Liang, M. Morrissey, and K. Shaw, Bioorg. Med. Chem. Lett. 10, 963 (2000).
62. (b) H. Zarrinmayeh, A. Nunes, P. Ornstein, D. Zimmerman, B, Arnold, D. Schober, S. Gackenheimer, R. Bruns, P. Hipskind, T. Britton, B. Cantrell, and D. Gehlert, J. Med. Chem. 41, 2709 (1998).
63. (c) J. Horn, Clin. Ther. 22, 266 (2000).
64. T. Nixey, P. Tempest, and C. Hulme, Tetrahedron Lett. 43, 1637 (2002).
65. K. Masumoto, 118th Annual Meeting of the Pharmacological Society of Japan, March 31-April 12, Kyoto, 1998, Abstr. 01(XD) 10-1.
66. 3CN to 100% over 5 min.
67. For an early application of the TMSN3-modified Ugi reaction producing fused tetrazoles see H. Bienayme, Tetrahedron Lett. 39, 2735 (1998).
68. T. Nixey, M. Kelly, D. Semin, and C. Hulme, Tetrahedron Lett. 43, 3681 (2002).
69. T. Nixey, M. Kelly, and C. Hulme, Tetrahedron Lett. 41, 8729 (2000).
70. (a) M. Passerini, Gazz. Chim. Ital. 51, 126 (1921).
71. (b) M. Passerini, Gazz. Chim. Ital. 51, 181 (1921).
72. (a) L. Banfi, G. Guanti, and R. Riva, Chem. Commun. 985 (2000).
73. (b) W. Jones, S. Tadesse, B. Chenera, V. Viswanadhan, and C. Hulme, A.C.S, 223nd American Chemical Society Meeting & Exposition, April 2002, New Orleans.
74. (a) B. M. Dunn, "Structure and Function of the Aspartic Proteases: Genetics, Structures, and Mechanisms," Vol. 306, p. xviii. Plenum Press, New York, 1991.
75. (b) K. Takahashi, "Aspartic Proteinases: Structure, Function, Biology, and Biomedical Implications." Plenum Press, New York, 1995.
76. (c) C. E. Lee, E. K. Kick, and J. A. Ellman, J. Am. Chem. Soc. 120, 9735 (1998) and references therein.
77. R. Vassar, B. Bennett, and S. Babu-Khan, Science 286, 735 (1999).
78. (a) D. Selkoe, Trends Cell Biol. 8, 447 (1998).
79. (b) D. Selkoe, Nature 399A, 23 (1999).
80. (c) S. Sinha and I. Lieberburg, Proc. Natl. Acad. Sci. USA 96, 11049 (1999).
81. T. Nixey and C. Hulme, Tetrahedron Lett. 43, 6833 (2002).
82. A. D. Abell and G. J. Foulds, J. Chem. Soc. Perkin Trans. 1 2475 (1997).
83. (a) J. Salvino, V. N. Kumar, E. Orton, J. Airey, T. Kiesow, K. Crawford, M. Rose, P. Krolikowski, M. Drew, D. Engers, D. Krolinkowski, T. Herpin, M. Gardyan, G. McGeehan, and R. Labaudiniere, J. Comb. Chem. 2, 691 (2000).
84. (b) M. Drew, E. Orton, P. Krolikowski, J. Salvino, and N. V. Kumar, J. Comb. Chem. 2, 8 (2000).
85. (c) W. Jones, D. Overland, L. Poppe, J. Cardenas, M. Pate, and C. Hulme, LabAutomation 2002, T002.
86. (a) R. W. Armstrong, S. D. Brown, T. A. Keating, and P. A. Tempest, in "Combinatorial Chemistry. Synthesis and Application" (S. R. Wilson and A. W. Czarnik, eds.), p. 153. John Wiley, New York, 1997.
87. (b) C. Blackburn, B. Guan, P. Fleming, K. Shiosaki, and S. Tsai, Tetrahedron Lett. 39, 3635 (1998).
88. (c) H. Bienayme and K. Bouzid, Angew. Chem. Int. Ed. Engl. 37, 2234 (1998).
89. (c) R. Bossio, S. Marcaccini, P. Paoli, and R. Pepino, Synthesis 672 (1994).
90. (d) S.-J. Park, G. Keum, S.-B. Kang, H.-Y. Koh, and Y. Kim, Tetrahedron Lett. 39, 7109 (1998).
91. (e) A. Domling, Comb. Chem. High Throughput Screen. 1, 1 (1998).
92. (f) S. L. Schreiber, Science 287, 1964 (2000).
93. (g) L. Weber, S. Wallbaum, C. Broger, and K. Gubernator, Angew. Chem. Int. Ed. Engl. 34, 2280 (1995).
94. (a) K. Rossen, P. J. Pye, L. M. DiMichele, R. P. Volante, and P. J. Reider, Tetrahedron Lett. 39, 6823 (1998).
95. (b) K. Rossen, J. Sager, and L. M. DiMichele, Tetrahedron Lett. 38, 3183 (1997).
96. S. L. Schreiber, Bioorg. Med. Chem. 6, 1127 (1998).